Streamline Your Antibody Discovery Workflow

Monoclonal antibodies are one of the fastest-growing classes of biopharmaceuticals and are the backbone of many treatment modalities.

Many antibodies engage the same target or target multple members of a single signaling pathway, therfore drug developers are pushing to produce next generation antibody drugs against new targets with improved mechanisms of action, pharmacokinetics and delivery systems. The Intellicyt® iQue Screener platform provides an integrated solution that produces rapidly acrtionable results.

Download this application note to discover how you can:

• Deliver rich content with lower sampling times
• Reduce assay volumes and save cell and reagent costs
• Dramatically reduce time and effort to generate useful results